Table II.
Placebo (%) | E2 (%) | E2 + DNase (%) | E2 + HI DNase (%) | |
---|---|---|---|---|
Transitional | 6/50 (12) | 12/52 (23)* | 8/63 (12.6)ns | 13/47 (29.7)* |
Mature | ||||
High affinity | 5/60 (8.3) | 18/62 (27.7)* | 8/72 (11.1)ns | 13/57 (22.8)* |
Low affinity | 11/60 (18) | 5/62 (8)* | 18/72 (25) | 4/57 (7)* |
A significant increase in high-affinity anti-DNA B cells in R4A Tg mice treated with E2 was observed and was abrogated by treatment with DNase, but not HI DNase. Fisher’s exact test was used to analyze significance between the various treatment groups compared with the P-treated group.
p < 0.05.
ns, Not significant.